Synergistic Influences of BMP9 and NGF on the Osteogenic Differentiation of C3H10T1/2 Mesenchymal Stem Cells

Overview

Journal J Orthop Surg Res

Publisher Biomed Central

Specialty Orthopedics

Date 2025 Mar 16

PMID 40089726

Authors

Junyu Liu

Kun Yang

Gang Li

Yinghui Tan

Affiliations

Soon will be listed here.

Abstract

Background: Bone morphogenetic protein 9 (BMP9) and nerve growth factor (NGF) are critical factors influencing osteogenic differentiation in mesenchymal stem cells (MSCs). While BMP9 has been recognized for its potent osteogenic capabilities, NGF's role in bone tissue engineering is less understood. This investigation delineated the synergistic link of BMP9 with NGF in driving osteogenic differentiation in C3H10T1/2 MSCs.

Objective: To evaluate the combined impact of BMP9 and NGF on osteogenic markers' expression levels and the formation of calcified nodules in C3H10T1/2 cells, providing a basis for the enhanced bone regeneration strategies in tissue engineering.

Methods: C3H10T1/2 cells were subjected to treatment regimens incorporating NGF at variable concentrations (10, 50, and 100 ng/ml) and BMP9, either as monotherapies or in combination. Osteogenic differentiation' comprehensive assessment was undertaken by quantifying early-stage markers (Runx2, Col I) and late-stage markers (OPN) via RT-PCR, Western blotting, ALP staining, and Alizarin Red S staining for mineralized matrix deposition.

Results: NGF elicited a concentration-dependent augmentation of early osteogenic markers, with the 10 ng/ml dosage demonstrating maximal efficacy. BMP9 independently facilitated robust osteogenic differentiation, whereas the combinatorial treatment with BMP9 and NGF synergistically amplified the expression levels of Runx2, Col I, and OPN. Notably, this combined treatment yielded a remarkable enhancement in the deposition of mineralized extracellular matrix, as evidenced by a notable escalation in the size and density of calcified nodules relative to monotherapies.

Conclusion: The findings unveiled the remarkable synergistic link of BMP9 with NGF in potentiating osteogenic differentiation in C3H10T1/2 MSCs. This dual-factor approach presents a compelling paradigm for advancing bone regeneration strategies, providing substantial promise for utilization in bone tissue engineering plus regenerative medicine.

References

Perez J, Kouroupis D, Li D, Best T, Kaplan L, Correa D . Tissue Engineering and Cell-Based Therapies for Fractures and Bone Defects. Front Bioeng Biotechnol. 2018; 6:105. PMC: 6079270. DOI: 10.3389/fbioe.2018.00105. View

Park J, Koh E, Seo Y, Oh H, Byun J . BMP-9 Improves the Osteogenic Differentiation Ability over BMP-2 through p53 Signaling In Vitro in Human Periosteum-Derived Cells. Int J Mol Sci. 2023; 24(20). PMC: 10607732. DOI: 10.3390/ijms242015252. View

Paz J, Adolpho L, Ramos J, Bighetti-Trevisan R, Calixto R, Oliveira F . Effect of Mesenchymal Stem Cells Overexpressing BMP-9 Primed with Hypoxia on BMP Targets, Osteoblast Differentiation and Bone Repair. Biology (Basel). 2023; 12(8). PMC: 10452403. DOI: 10.3390/biology12081147. View

Lian M, Qiao Z, Qiao S, Zhang X, Lin J, Xu R . Nerve Growth Factor-Preconditioned Mesenchymal Stem Cell-Derived Exosome-Functionalized 3D-Printed Hierarchical Porous Scaffolds with Neuro-Promotive Properties for Enhancing Innervated Bone Regeneration. ACS Nano. 2024; 18(10):7504-7520. DOI: 10.1021/acsnano.3c11890. View

Ji Y, Mao Y, Lin H, Wang Y, Zhao P, Guo Y . Acceleration of bone repairation by BMSCs overexpressing NGF combined with NSA and allograft bone scaffolds. Stem Cell Res Ther. 2024; 15(1):194. PMC: 11218317. DOI: 10.1186/s13287-024-03807-z. View

Chen Y, Zhao X, Wu H . Transcriptional Programming in Arteriosclerotic Disease: A Multifaceted Function of the Runx2 (Runt-Related Transcription Factor 2). Arterioscler Thromb Vasc Biol. 2020; 41(1):20-34. PMC: 7770073. DOI: 10.1161/ATVBAHA.120.313791. View

Liu Z, Suh J, Deng P, Bezouglaia O, Do M, Mirnia M . Epigenetic Regulation of NGF-Mediated Osteogenic Differentiation in Human Dental Mesenchymal Stem Cells. Stem Cells. 2022; 40(9):818-830. PMC: 9512103. DOI: 10.1093/stmcls/sxac042. View

Kusuyama J, Seong C, Nakamura T, Ohnishi T, Amir M, Shima K . BMP9 prevents induction of osteopontin in JNK-inactivated osteoblasts via Hey1-Id4 interaction. Int J Biochem Cell Biol. 2019; 116:105614. DOI: 10.1016/j.biocel.2019.105614. View

Li Q, Wu D, Li R, Zhu X, Cui S . Valproic acid protects neurons and promotes neuronal regeneration after brachial plexus avulsion. Neural Regen Res. 2014; 8(30):2838-48. PMC: 4146011. DOI: 10.3969/j.issn.1673-5374.2013.30.006. View

10.

Yao X, Li P, Deng Y, Yang Y, Luo H, He B . Role of p53 in promoting BMP9‑induced osteogenic differentiation of mesenchymal stem cells through TGF‑β1. Exp Ther Med. 2023; 25(6):248. PMC: 10160913. DOI: 10.3892/etm.2023.11947. View

11.

Cui J, Zhang W, Huang E, Wang J, Liao J, Li R . BMP9-induced osteoblastic differentiation requires functional Notch signaling in mesenchymal stem cells. Lab Invest. 2018; 99(1):58-71. PMC: 6300564. DOI: 10.1038/s41374-018-0087-7. View

12.

Seong C, Chiba N, Kusuyama J, Amir M, Eiraku N, Yamashita S . Bone morphogenetic protein 9 (BMP9) directly induces Notch effector molecule Hes1 through the SMAD signaling pathway in osteoblasts. FEBS Lett. 2020; 595(3):389-403. DOI: 10.1002/1873-3468.14016. View

13.

Cheng C, Tang S, Cui S, Yang T, Li L, Zhai M . Nerve growth factor promote osteogenic differentiation of dental pulp stem cells through MEK/ERK signalling pathways. J Cell Mol Med. 2024; 28(4):e18143. PMC: 10853700. DOI: 10.1111/jcmm.18143. View

14.

Lu X, Li L, Wu N, Chen W, Hong S, Xu M . BMP9 functions as a negative regulator in the myogenic differentiation of primary mouse myoblasts. Biosci Biotechnol Biochem. 2023; 87(11):1255-1264. DOI: 10.1093/bbb/zbad104. View